Clinical Robotic Surgery Association (CRSA) launched in India

IMT News Desk
IMT News Desk
· 2 min read

August 23, 2019, New Delhi: We are pleased to announce the inaugural meeting of Clinical Robotic Surgery Association (CRSA), Indian Chapter, on August 24-25 in Hotel Le Meridien, New Delhi. Robotic Surgery is the latest advancement in the field of surgery. It involves using computer assistance and artificial intelligence to help do complex surgical procedures with precision and best clinical outcomes.

Clinical Robotic Surgery Association (CRSA) is the leading body of experts in the field of Robotic Surgery across the world, based out of Chicago, USA. It has started with the first international chapter in India. The inaugural meeting of the chapter is being done in New Delhi on August 24-25, 2019 at Hotel Le Meridien.

This is the first Indian robotic surgery society. The inaugural meeting of CRSA India will see leading surgeons from all over the country and abroad come together and share their knowledge and wisdom in the field of robotic surgery. CRSA India would also provide training opportunities to young surgeons who want to train themselves in the field of Robotic Surgery. It would help surgeons learn from the best experts with the help of a peer reviewed journal and online video library. The members can access the surgical techniques of experts, and visit them for further training.

Honorable speaker of Lok Sabha, Sh. Om Birla will be the chief guest for the inaugural event. Prof. Ranjan Sudan, Professor of Surgery and Vice-Chair of Education at Duke University who is current worldwide president of CRSA would be the guest of honor.

More than 250 surgeons from across the country and abroad have registered for the meeting. There will be hands on training opportunity on the robotic system and simulator for the surgeons who attend the meeting. The proceedings of the meeting would be shared live online. There would be panel discussions between experts in the field to share ideas, and reach conclusions in gray areas.

Dr. Vivek Bindal, Chapter Regent, CRSA India said “With this launch of Indian robotic surgery society, both surgeons and patients would be benefited. It would lead to better training and mentoring opportunities for surgeons, and the society would formulate norms to ensure safe surgery for patients. Also, there will be opportunities for visiting centers of excellence throughout the world, and gain knowledge and skillset in the field of robotic surgery”.

 

Read Next

India successfully validates the first indigenous HPV test for Cervical Cancer screening
News
June 13, 2026

India successfully validates the first indigenous HPV test for Cervical Cancer screening

India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country’s first indigenous HPV DNA tests, which meet international standards for cervical cancer screening. Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics Truenat HPV-HR Plus met the […]
Article by: IMT News Desk
Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk